Remove Cardiovascular Disease Remove Cerebrovascular Disease Remove Coronary Artery Disease
article thumbnail

Lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients in non-metropolitan area of Brandenburg, Germany

Frontiers in Cardiovascular Medicine

Background and aims In the non-metropolitan region of Brandenburg (Germany), which is characterized by high rates of cardiovascular diseases and underserved medical care, there is a lack of awareness regarding lipoprotein(a) [Lp(a)] as a risk factor. 3.95, p  = 0.003). 3.95, p  = 0.003). vs. 45.8%; 17.6% vs. 13.9%, p  = 0.001).

article thumbnail

Gestational diabetes mellitus and development of intergenerational overall and subtypes of cardiovascular diseases: a systematic review and meta-analysis

Cardiovascular Diabetology

Objective We aimed to summarize the association between gestational diabetes mellitus (GDM) and its intergenerational cardiovascular diseases (CVDs) impacts in both mothers and offspring post-delivery in existing literature.

article thumbnail

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

DAIC

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 24,25 Among statin-treated patients with hsCRP greater than 2 mg/L, risks for cardiovascular death were high regardless of LDL-C level.21 4 In the U.S.

article thumbnail

Intermediate and long-term residual cardiovascular risk in patients with established cardiovascular disease treated with statins

Frontiers in Cardiovascular Medicine

Methods This narrative review examines the contemporary literature assessing intermediate- and long-term event rates in patients with established CV disease treated with statins. Recurrent stroke occurs in up to 19% of patients seven years after a first cerebrovascular event.

article thumbnail

Epidemiology of atherosclerotic cardiovascular disease in polygenic hypercholesterolemia with or without high lipoprotein(a) levels

Frontiers in Cardiovascular Medicine

Background and aims Epidemiology of atherosclerotic cardiovascular disease might be different in patients with polygenic hypercholesterolemia plus high levels (≥30 mg/dl) of Lp(a) (H-Lpa) than in those with polygenic hypercholesterolemia alone (H-LDL).

article thumbnail

Artificial intelligence and cardiology

Cardiomatics

According to WHO , cardiovascular diseases are the leading cause of death worldwide – it is estimated that they are the cause of 17.9 Cardiovascular diseases are a group of diseases of the heart and blood vessels. They include coronary artery disease, cerebrovascular disease, and rheumatic heart disease.